Article focus {#section5-2046-3758.82.BJR-2018-0134.R1}
=============

-   In recent years, researchers have produced bioartificial substitutes that restore the function of damaged organs by combining cells, biomaterials, and growth factors.

-   Meniscal tissue regeneration strategies have been the subject of significant research interest.

-   In this article, we report the development of a cellularized human meniscus using 3D bioprinting technology.

Key messages {#section6-2046-3758.82.BJR-2018-0134.R1}
============

-   With 3D bioprinting, it is possible to create a cellularized meniscus substitute.

-   This technology is emerging as a novel strategy to promote tissue repair for different clinical applications.

Strengths and limitations {#section7-2046-3758.82.BJR-2018-0134.R1}
=========================

-   No previous study reports the creation of a cellularized custom-made meniscus using 3D bioprinting technology.

-   Meniscal structure plays a key role in joint load distribution, but this aspect has not been investigated.

-   Future studies should investigate the maturation of this construct and document the final biomechanical properties obtained, as well as their effectiveness in protecting the joint surfaces.

Introduction {#section8-2046-3758.82.BJR-2018-0134.R1}
============

The menisci of the knee consist of two semilunar fibrocartilage structures located at the medial and lateral articular surfaces of the tibial plateau, where they contribute to stabilization, nourishment, and force distribution.^[@bibr1-2046-3758.82.BJR-2018-0134.R1]^ Meniscal lesions represent the most common surgically treated knee pathology, with 850 000 meniscal procedures performed in the United States every year.^[@bibr2-2046-3758.82.BJR-2018-0134.R1]^ Meniscectomy procedures, which are carried out to reduce pain and to recover satisfactory knee function, are often unavoidable when treating meniscal tears.^[@bibr3-2046-3758.82.BJR-2018-0134.R1]^ Since injury or surgery can result in the substantial loss of meniscal tissue, can permanently alter joint homeostasis, and can lead to a high risk of osteoarthritis, alternative surgical options have been developed to restore the biomechanical environment of the knee.^[@bibr4-2046-3758.82.BJR-2018-0134.R1]^

The management of meniscal pathology is therefore focused on preserving meniscal tissue to the greatest extent possible. Meniscal allografts are currently the preferred treatment for patients who have previously had a total or subtotal meniscectomy, with good results reported at long-term follow-up.^[@bibr5-2046-3758.82.BJR-2018-0134.R1],[@bibr6-2046-3758.82.BJR-2018-0134.R1]^ However, there are multiple drawbacks to meniscal allograft transplantation, such as limits in tissue availability, the risk of mismatch and immunoreactivity, impaired cellular infiltration and remodelling capacity, and suboptimal prognosis with results worsening over time.^[@bibr7-2046-3758.82.BJR-2018-0134.R1],[@bibr8-2046-3758.82.BJR-2018-0134.R1]^ To overcome the limitations of allografts, several scaffolds have been developed,^[@bibr9-2046-3758.82.BJR-2018-0134.R1]^ but, despite promising preclinical findings, only two cell-free meniscal substitutes have reached clinical practice and been used to address partial meniscus defects: one collagen-based meniscal implant and one consisting of polyurethane and polycaprolactone.^[@bibr10-2046-3758.82.BJR-2018-0134.R1]^ Safety and positive clinical results have been reported for both scaffolds, with imaging and, in some cases, arthroscopic evaluation confirming the potential of these bio-engineered devices to stimulate meniscal tissue regeneration, albeit not completely.^[@bibr9-2046-3758.82.BJR-2018-0134.R1],[@bibr11-2046-3758.82.BJR-2018-0134.R1],[@bibr12-2046-3758.82.BJR-2018-0134.R1]^ Further to the limited regenerative potential, the mismatch between these crescent-shaped implants and the patient-specific lesion areas is a key issue, as it has been demonstrated that even small changes in implant positioning may affect contact pressure and joint stress.^[@bibr13-2046-3758.82.BJR-2018-0134.R1]^ To address the limits of meniscus implantation, and to optimize the restoration of meniscal function and joint integrity over time, implants could be developed with an enhanced biological potential and patient-specific sizing to meet individuals' joint requirements.

The aim of this study was therefore to develop and document the preliminary findings of an implant prototype based on 3D bioprinting of human, cell-laden, patient-specific collagen scaffold for meniscus regeneration.

Materials and Methods {#section9-2046-3758.82.BJR-2018-0134.R1}
=====================

Isolation and expansion of mesenchymal stem cells (MSCs) {#section10-2046-3758.82.BJR-2018-0134.R1}
--------------------------------------------------------

Bone marrow was obtained from the iliac crest of a patient undergoing autologous cell transplantation for the treatment of osteochondral defects. All investigations were conducted in conformity with the ethical principles of research and samples were anonymized. Bone-marrow-derived MSCs were isolated using Ficoll-Hypaque density gradient (d = 1.077 g/ml) from Pharmacia Biotech (Uppsala, Sweden) as previously reported, and were plated at a concentration of 3 × 10^6^ cells/T150 flask.^[@bibr14-2046-3758.82.BJR-2018-0134.R1]^ After seven days, adherent cells were expanded *in vitro* and successively plated at 3 × 10^5^ cells/T150 flask under conventional monolayer culture conditions. Once a sufficient number of cells were available, usually after the third to fourth passage, MSCs were used for cell-laden bio-ink preparation.

Cell-laden bio-ink preparation {#section11-2046-3758.82.BJR-2018-0134.R1}
------------------------------

LifeInk 200 purified, highly concentrated Type I Collagen bio-ink was purchased from Advanced Biomatrix (San Diego, California). The cell-laden bio-ink was realized in accordance with the manufacturer's instructions. Briefly, highly concentrated collagen was first neutralized by connecting the provided syringe through a sterile coupler to a 3 ml syringe containing 200 μl of sterile 1 M hydrochloric acid (HCl; Fisher Scientific Italia, Rodano, Italy), carefully avoiding introducing air. The plungers of the two syringes were then pushed back and forth at least 40 times to ensure thorough mixing of the collagen and HCl. The same procedure was repeated with the collagen syringe connected to a 3 ml syringe containing 200 μl of sterile 1 M sodium hydroxide (NaOH; Carlo Erba, Milan, Italy). After neutralization, the cell addition process was performed by dispensing concentrated chilled MSCs (38 × 10^6^) to a 3 ml sterile syringe, connected through a sterile coupler to the neutralized collagen syringe. The two plungers were then pushed back and forth 40 times to ensure thorough mixing. The collagen bio-ink was kept chilled at all times.

3D modelling and bioprinting of a meniscal structure {#section12-2046-3758.82.BJR-2018-0134.R1}
----------------------------------------------------

In order to ensure that the bioprinted meniscus mimicked a natural one, the 3D model of bioengineered tissue was based on MRI scans of a human volunteer's medial meniscus. The images were acquired using the 3Tesla Discovery MR750w GEM Magnetic Resonance imaging system (GE Healthcare, Little Chalfont, United Kingdom) with a 16-element phased-array flexible coil. The knee was scanned in the supine position with a relaxed limb. For image acquisition, a sagittal 3D fast-spin-echo (FSE) Cube scan in proton density (PD) was performed. The 3D-FSE-Cube scan in PD is a volumetric sequence with high spatial and contrast resolution. The image parameters used in the sequences are reported in [Table I](#table1-2046-3758.82.BJR-2018-0134.R1){ref-type="table"}. The 3D-FSE-Cube sequence uses a 2D reconstruction technique based on parallel imaging (ARC, Auto Calibrating Reconstruction for Cartesian Imaging; GE Healthcare).

###### 

MRI scan parameters for knee imaging data acquisition

  FOV, mm     Matrice     TR, ms   TE, ms   Slice thickness, mm   Bandwidth, kHz   Echo train length   NEX   Scan time, mins
  ----------- ----------- -------- -------- --------------------- ---------------- ------------------- ----- -----------------
  180 × 180   320 × 320   1500     32       0.80                  83.33            60                  1     6.32

FOV, field of view; TR, repetition time; TE, echo time; NEX, number of excitations

The Digital Imaging and Communications in Medicine (DICOM) data from the MRI imaging of the meniscus were processed using the dedicated software 'Mimics' (Materialise, Leuven, Belgium) in order to obtain an STL model of the structure. Starting from an automatic threshold, the model was subsequently adjusted by means of a manual segmentation process, with the help of an orthopaedic surgeon (GF), in order to reconstruct the medial meniscus 3D morphology. During this phase, an extension was added to both meniscal horns. This modification was made with the aim of favouring a possible surgical anchoring of the structure. The resulting STL model is shown in [Figure 1](#fig1-2046-3758.82.BJR-2018-0134.R1){ref-type="fig"}. Later, a series of 2D cross-sections were sliced from the STL model, and tool paths were generated using computer-aided manufacturing software (BioCAM; RegenHU, Villaz-St-Pierre, Switzerland). LifeInk 200 bio-ink with embedded MSCs (38 × 10^6^) was loaded into a disposable cartridge. The chosen 3D Discovery printing tool (RegenHU) was a microvalve-based inkjet printhead. This instrument consists of multiple printheads that have the capability to deposit different types of thermoplastic polymers and cell-laden hydrogels. A tri-axis (x,y,z) motion system enables 3D patterning of multiple materials in order to fabricate custom-made tissues in multiple shapes and sizes. An air pressure controller regulates precise dispensing of materials, and separate thermal control circuits allow the cartridge and collector temperatures to be set. Human Machine Interface (HMI) Software (RegenHU) allows different tool printing parameters to be controlled. The valve opening time was set at 190 μs and the dosing distance was set at 0.065 mm. The printing speed was set to 12 mm/s at a pressure of 0.2 bar, setting a height for each layer of 0.25 mm and a rectilinear filling pattern with 50% density. The printing process was performed in culture medium inside a sterile Petri dish, kept at 37°C.

![STL model of a human meniscus.](bonejointres-08-101-g001){#fig1-2046-3758.82.BJR-2018-0134.R1}

Cell viability: LIVE/DEAD assay {#section13-2046-3758.82.BJR-2018-0134.R1}
-------------------------------

Realized cell-laden constructs carrying MSCs were put onto 24-well plates, supplemented with Eagle's minimum essential medium alpha modification (α-MEM) and cultured under conventional conditions at 37°C in a humidified atmosphere of 5% CO~2~ for up to 28 days. To differentiate between live and dead cells, at the end of the planned experimental times (five and 28 days), all samples were washed in Dulbecco\'s phosphate-buffered saline (DPBS) and then incubated in the staining solution of the LIVE/DEAD Cell Imaging Kit (Thermo Fisher Scientific, Waltham, Massachusetts) for 45 minutes. After staining, samples were washed three times in DPBS for 15 minutes and then embedded in organic cation transporter, snap-frozen in liquid nitrogen, cut into 5 µm to 10 µm sections, air-dried, and stored at -20°C. Slides were evaluated using an Eclipse 90i fluorescence microscope (Nikon, Tokyo, Japan) equipped with a digital camera.

Results {#section14-2046-3758.82.BJR-2018-0134.R1}
=======

3D modelling and bioprinting of a meniscal structure {#section15-2046-3758.82.BJR-2018-0134.R1}
----------------------------------------------------

A custom-made human cell-laden collagen meniscus was realized, using MRI images of a healthy volunteer as a starting point. The selected bio-ink presented good printability and shape fidelity, allowing the fabricated tissue, obtained by means of a microvalve-based inkjet dispensing technique, to mimic the anatomical model morphology ([Fig. 2](#fig2-2046-3758.82.BJR-2018-0134.R1){ref-type="fig"}). This 'cell-friendly' technology allowed MSCs included in the bio-ink to be homogeneously distributed within the construct.

![Photograph of a custom-made, human, cell-laden, high-density collagen type I meniscus prototype after mesenchymal stem cells were embedded. The printing process was performed at room temperature in a Petri dish filled with culture medium and kept at 37°C.](bonejointres-08-101-g002){#fig2-2046-3758.82.BJR-2018-0134.R1}

Cell viability: LIVE/DEAD assay {#section16-2046-3758.82.BJR-2018-0134.R1}
-------------------------------

The LIVE/DEAD assay showed that at five days, only about 50% of the seeded cells were alive ([Fig. 3](#fig3-2046-3758.82.BJR-2018-0134.R1){ref-type="fig"}), indicating that the bioprinting procedure could affect cell viability, perhaps due to the partially altered culture conditions occurring during this process (such as temperature and pH). However, after a culture of 28 days, almost all of the remaining cells were viable; these cells were able to grow and to colonize the biomaterial, demonstrating that the bioprinted collagen-based hydrogel scaffold provides a good microenvironment for the viability and proliferation of MSCs.

![LIVE/DEAD images of cell-laden collagen type I gel scaffolds. Viable cells are in green and dead cells in red. The top row shows slides from total meniscus structure, while the bottom row shows slides from cubical constructs. Images are representative.](bonejointres-08-101-g003){#fig3-2046-3758.82.BJR-2018-0134.R1}

Discussion {#section17-2046-3758.82.BJR-2018-0134.R1}
==========

The development of biomaterials that are able to stimulate meniscus regeneration is promising, and could potentially reduce the need for patients to undergo invasive surgery at a young age.^[@bibr10-2046-3758.82.BJR-2018-0134.R1]^ Both synthetic and biological materials have been developed: polyurethane meniscus implants,^[@bibr15-2046-3758.82.BJR-2018-0134.R1]^ silk fibrous protein scaffolds,^[@bibr16-2046-3758.82.BJR-2018-0134.R1]^ and hyaluronic acid/polycaprolactone scaffold^[@bibr17-2046-3758.82.BJR-2018-0134.R1]^ have been used to simulate the architecture and function of the meniscus.^[@bibr18-2046-3758.82.BJR-2018-0134.R1]^ Since no comparative studies have been performed to prove the superiority of one biomaterial over others, and considering that collagen makes up 22% of the normal human meniscus,^[@bibr19-2046-3758.82.BJR-2018-0134.R1]^ collagen was chosen to develop this tissue-engineered meniscus prototype.

Collagen-based hydrogels can enhance tissue regeneration by providing biochemical signals that induce cellular differentiation and migration.^[@bibr20-2046-3758.82.BJR-2018-0134.R1],[@bibr21-2046-3758.82.BJR-2018-0134.R1]^ Cell-free scaffolds are usually preferred as strategies for meniscal replacement, in order to avoid the costs and potential risks related to cell manipulation,^[@bibr9-2046-3758.82.BJR-2018-0134.R1]^ as well as the regulatory limitations that may hinder a subsequent translation in clinical practice. However, although it is not possible to draw definitive conclusions on the real effectiveness of cell augmentation from the few comparative studies that are currently available, previous animal trials have suggested that cell augmentation might provide superior regenerative potential.^[@bibr17-2046-3758.82.BJR-2018-0134.R1],[@bibr22-2046-3758.82.BJR-2018-0134.R1]^ The combination of scaffolds and cells has therefore been investigated,^[@bibr9-2046-3758.82.BJR-2018-0134.R1]^ with the aim of enhancing tissue quality. This previous research informed the approach used when creating the prototype discussed in this paper. Since inaccurate sizing can adversely affect function of a meniscal substitute,^[@bibr23-2046-3758.82.BJR-2018-0134.R1],[@bibr24-2046-3758.82.BJR-2018-0134.R1]^ MRI-guided 3D bioprinting was used to produce a patient-specific implant.

This technology, which is based on additive manufacturing or 'rapid prototyping', has the ability to create complex, cellularized structures with anatomical precision, enabling the fabrication of design-specific tissue constructs. In bioprinting, small units of cells and biomaterials are dispensed with micrometre precision to form tissue-like structures. Conventional 3D printing techniques have been utilized to print temporary cell-free scaffolds for use in surgery. However, bioprinting requires a different technical approach that is compatible with depositing living cells, with the advantages of accurate control of cell distribution, high-resolution cell deposition, scalability, and cost-effectiveness. While developing a 3D bioprinted tissue, several aspects must be considered beyond the choice of material. Density is another factor that may affect the final *in vivo* outcome; inappropriate density might impede cellular and tissue ingrowth within the scaffold, thus delaying its incorporation and promoting an encapsulation response.^[@bibr25-2046-3758.82.BJR-2018-0134.R1]^ Cell encapsulation inside collagen gels, in which the fibre network allows the physical entrapment of cells, is a commonly used method in tissue engineering. Moreover, collagen gel pore size is dependent on concentration, and therefore it may be adjusted for different applications and cell types.^[@bibr26-2046-3758.82.BJR-2018-0134.R1]^

The prototype described in this study has been conceived as a 3D bioprinted, collagen-based, cell-laden scaffold. In this setting, one of the challenges faced is that a compromise must be reached in terms of temperature, in order to avoid collagen gel thermal crosslinking within cartridge and needle clogging phenomena, on the one hand, and to favour the geometric fidelity and survival rate of embedded cells, on the other. Biological and printability requirements, which often oppose each other, must both be met (i.e. conditions must fall within the 'biofabrication window').^[@bibr27-2046-3758.82.BJR-2018-0134.R1]-[@bibr29-2046-3758.82.BJR-2018-0134.R1]^ To reach this goal in the current study, the cartridge was kept at room temperature while printing in a support filled with culture medium kept at 37°C, as suggested by the bio-ink producer. Since cell viability is the premise for the development of a tissue-engineering strategy, cells were evaluated for up to four weeks, demonstrating the 3D bioprinter ability to deposit biomaterials in cell-friendly conditions, with the advantage of controlling both overall 3D macrostructure and cell distribution, thus overcoming the limits of other scaffold production technologies.^[@bibr30-2046-3758.82.BJR-2018-0134.R1]^

This study is not without limitations. The construct should possess sufficient mechanical strength to withstand the stress generated by load *in vivo*, which is particularly relevant for tissue-engineered meniscus.^[@bibr31-2046-3758.82.BJR-2018-0134.R1]^ While the requirement of biomechanical property should also be kept in mind for a structure that plays a key role in joint load distribution, this aspect has not been investigated. The bioprinting technology used did not allow the complex structure and organization of the collagenous matrix, which is crucial for the meniscus to withstand the mechanical function of load-bearing under physiological conditions, to be recreated.^[@bibr32-2046-3758.82.BJR-2018-0134.R1]^ Future application of this prototype in a bioreactor-based tissue engineering strategy should provide the necessary stimuli to induce physiological fibre alignment and zonal organization, as previously shown in other tissue-engineering models.^[@bibr33-2046-3758.82.BJR-2018-0134.R1]-[@bibr35-2046-3758.82.BJR-2018-0134.R1]^ Finally, while MSCs have been used in this study as meniscal substitute, other cell sources should also be explored and compared to optimize this construct, and to ensure that it is as similar as possible to a native meniscus.^[@bibr36-2046-3758.82.BJR-2018-0134.R1],[@bibr37-2046-3758.82.BJR-2018-0134.R1]^

The prototype described in this study showed the biological potential of 3D bioprinting technology in providing an anatomically shaped, patient-specific construct with viable cells on a biocompatible material. This study could act as the starting point for future developments of this custom-made, collagen-based, tissue-engineered structure, which could aid the optimization of implants designed to replace damaged menisci.
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